Seroprevalence of Chlamydia pneumoniae infection in Taiwan

Journal of Infection

Volumn 48, Issue 1, 2004, Pages 91-95

  Lin, T M ^a   Kuo, C C ^b   Chen, W J ^c   Lin, F J H ^c   Eng, H L ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Chlamydia pneumoniae; Microimmunofluorescence antibody assay; Seroprevalence; Taiwan

Indexed keywords

BACTERIUM ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; BLOOD; BLOOD SAMPLING; CHI SQUARE DISTRIBUTION; CHILD; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ENDEMIC DISEASE; EPIDEMIOLOGY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOLOGY; INFANT; MALE; PRESCHOOL CHILD; SEROPREVALENCE; SYMPTOMATOLOGY; TAIWAN;

EID: 0347917219     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(03)00129-4     Document Type: Article

References (26)

1. Ben-Yaakov M, Lazarovich I, Beer S, Shoham I, Boldur I. Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel. J Clin Pathol 1994;47:232-235.
2. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-625.
3. Grayston JT, Wang S-P, Kuo CC, Campbell LA. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory disease. Eur J Clin Microbiol Infect Dis 1989;8:191-202.
4. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995;8:451-461.
5. Hyman CL, Robin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MRN. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 1995;20:1174-1178.
6. Montes M, Cilla G, Alcorta M, Perez-Trallero E. High prevalence of Chlamydia pneumoniae infection in children and young adults in Spain. Pediatr Infect Dis J 1992;11: 972-973.
7. Saikku P, Wang S-P, Kleemola M, Brander E, Rusanen E, Grayston JT. An epidemic of mild pneumoniae due to unusual strain of Chlamydia psittaci. J Infect Dis 1985;151:832-839.
8. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 1994;32:903-905.
9. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesion of cononary arteries. J Infect Dis 1993;167: 84-89.
10. Saikku P. Chlamydia pneumoniae in atherosclerosis. J Intern Med 2000;247:391-396.
11. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1989;266:225-230.
12. Braun JB, Laitko S, Treharne J, et al. Chlamydia pneumoniae - a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994;53: 100-105.
13. Einarsson S, Sigurdsson HK, Magnusdottir SD, Erlendsdottir H, Briem H, Gudmundsson S. Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland. Scand J Infect Dis 1994;26:393-397.
14. Kerm DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Chest 1993;104: 208-213.
15. Aldous MS, Grayston JT, Wang S-P. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis 1992;166:646-649.
16. Karvonen M, Tuomilehto J, Naukkarinen A, Saikku P. The prevalence and regional distribution of antibodies against Chlamydia pneumoniae (strain TWAR) in Finland in 1958. Int J Epidemiol 1992;21:391-398.
17. Kese D, Hren-Vencelj H, Socan M, Beovic B, Cizman M. Prevalence of antibodies to Chlamydia pneumoniae in Slovenia. Eur J Clin Microbiol Infect Dis 1994;13:523-525.
18. Wang S-P, Grayston JT. Microimmunofluorence serological studies with the TWAR organism. In: Oriel JD, Ridgway G, Schachater J, Taylor-Robinson D, Ward M, editors. Chlamydial infection. Cambridge, England: Cambridge University Press; 1986. p. 329-332.
19. Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR. Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol 1998;36:3426-3428.
20. Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J Clin Microbiol 1991;29:816-818.
21. Karvonen M, Tuomilehto J, Pitkaniemi J, Saikku P. The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland 1972-1987. Epidemiol Infect 1993;110: 349-360.
22. Wang JH, Liu YC, Cheng DL, Yen MY, Chen YS, Chen BC. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis 1993;25:565-568.
23. Gnarpe H, Gnarpe J. Increasing prevalence of specific antibodies to Chlamydia pneumoniae in Sweden. Lancet 1993;341:381.
24. Ni AP, Lin GY, Yang L, et al. A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China. Scand J Infect Dis 1996;28: 553-557.
25. Mahmoud E, Elshibly S, Mardh PA. Seroepidemiologic study of Chlamydia pneumoniae and other chlamydial species in a hyperendemic area for trachoma in the Sudan. Am J Trop Med 1994;31:489-494.
26. Saikku P. The epidemiology and significance of Chlamydia pneumoniae. J Infect Dis 1992;25(Suppl. 1): 27-34.